Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02282865
Other study ID # 4-2014-0599
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 11, 2014
Est. completion date March 3, 2017

Study information

Verified date January 2019
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Heart rate variability (HRV) is known to reflect the balance of autonomic nervous system. Anxiousness, which tend to result from the deficient action of parasympathetic nervous system, likely to show low HRV. This study is to investigate the relationship between the surgery-related anxiety and the HRV which is known to reflect the balance of autonomic nervous system. Furthermore, this study also focuses on HRV's role as a predictor for aggressive emergence behavior, which might also be considered as partially related to imbalance of autonomic nervous system.


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date March 3, 2017
Est. primary completion date March 3, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria:

1. 20-60 years old male, ASA 1-2

2. scheduled for elective closed reduction for nasal bone fracture

Exclusion Criteria:

1. Patients having hearing difficulties, Foreigner, taking any CNS related medication, history of any adverse drug reaction, Glasgow coma scale < 15

2. patients with severe cardiopulmonary dysfunction

3. patients taking any neurologic medication (anti-depressant, anti-convulsant, etc)

4. patients taking any cardiovascular medication

5. patients taking medications affecting the autonomic nervous system (a-blocker, b-blocker, etc)

6. patients refusal

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary High frequency (HF) of Heart Rate Variability (HRV) High frequency (HF) component of HRV, which represents the parasympathetic activity from immediately after tracheal intubation to 5 min after tracheal intubation